Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Gregory Lewis initiated coverage on Iperionx Ltd (NASDAQ:IPX) with a Buy rating and announced a price target of $40. IperionX shares closed at $21.98 on Thursday. See how other analysts view this stock.
- Needham analyst Joseph Stringer initiated coverage on BIOAGE Labs Inc (NASDAQ:BIOA) with a Buy rating and announced a price target of $50. Bioage Labs shares closed at $16.25 on Thursday. See how other analysts view this stock.
- Wolfe Research analyst Kalpit Patel initiated coverage on Genmab A/S – ADR (NASDAQ:GMAB) with an Outperform rating and announced a price target of $32. Genmab shares closed at $26.03 on Thursday. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert initiated coverage on Heartbeam Inc (NASDAQ:BEAT) with a Buy rating and announced a price target of $5. HeartBeam shares closed at $1.09 on Thursday. See how other analysts view this stock.
- BMO Capital analyst Daniel DiCicco initiated coverage on Honeywell International Inc (NASDAQ:HON) with an Outperform rating and announced a price target of $273. Honeywell shares closed at $225.17 on Thursday. See how other analysts view this stock.
Considering buying HON stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment